SCHEMBL7378385

SCHEMBL7378385

[NH]C(=O)c1ccc2cn[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.55
DYRK1A Q13627 3/20 0.51
MAP4K4 O95819 1/20 0.51
CLK2 P49760 1/20 0.51
SRPK1 Q96SB4 1/20 0.51
CLK4 Q9HAZ1 1/20 0.51
NOS1 P29475 3/20 0.50
MAPT P10636 3/20 0.50
METAP2 P50579 2/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 2/20 0.49
FGFR1 P11362 2/20 0.49
FGFR2 P21802 1/20 0.49
FGFR3 P22607 1/20 0.49
CYP3A4 P08684 2/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8521917 0.86 CTNNB1 (0.59) MAOBDYRK1AMAP4K4CLK2CLK4
SCHEMBL29365815 0.84 ALDH1A1 (0.56) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL260992 0.84 ALDH1A1 (0.56) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL30194367 0.82 MAPT (0.68) MAOBDYRK1AMAP4K4CLK2SRPK1
Hydrochloric Acid SCHEMBL7001071 0.82 ALDH1A1 (0.55) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL475069 0.82 AR (0.63) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL2933207 0.82 MAPT (0.68) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL20187143 0.82 MAOB (0.58) MAOBDYRK1AMAP4K4CLK2SRPK1
SCHEMBL29887527 0.82 AR (0.63) MAOBDYRK1AMAP4K4CLK2SRPK1
Hydrochloric Acid SCHEMBL31173861 0.81 AR (0.61) MAOBDYRK1AMAP4K4CLK2SRPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939757-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS Dupont Pharmaceuticals Company (US) 1999-09-08 EP disclosed
WO-1998043962-A1 HETEROCYCLIC INTEGRIN INHIBITOR PRODRUGS DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-08 WO disclosed
WO-1997023480-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-07-03 WO disclosed